remifentanil has been researched along with Liver Dysfunction in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Alterovitz, G; Bai, Y; Bi, Y; Chen, H; Chen, X; Dai, H; Durrani, TS; Farooqi, A; Fatibello-Filho, O; Gao, L; Gong, L; Greenwell, K; Guo, YX; Han, D; He, L; Howells, L; Huang, H; Huang, S; Jester, N; Jiang, PP; Kang, P; Kang, Y; Kraemer, R; Lan, X; Lawton, S; Li, C; Li, H; Liu, G; Liu, J; Liu, P; Matthys, H; Meng, Y; Moraes, FC; Muller, I; Pan, C; Qu, L; Roberts, A; Santer, M; Silva, LP; Silva, TA; Sivyer, K; Smith, HJ; Song, F; Steele, M; Sun, N; Teasdale, E; Tong, Y; Wang, D; Wang, L; Wang, Q; Wang, S; Xiao, M; Xin, D; Xu, C; Xu, J; Yang, XL; Zhang, B; Zhang, D; Zhang, J; Zhang, L; Zhang, Q; Zhong, L; Zhu, H | 1 |
| Kim, GS; Park, IH; Park, M | 1 |
| Jiao, Y; Liu, X; Liu, Y; Su, D; Tian, J; Wang, X; Yang, H; Yang, L; Yu, W | 1 |
| Sclar, DA | 1 |
| Cheung, CW; Irwin, MG; Liu, YT; Lv, H; Song, JG; Tao, KM; Wong, GT; Wu, FX; Yang, LQ; Yu, WF | 1 |
| Chen, QL; Huang, SQ; Wu, J; Zheng, SS | 1 |
| Kreuer, S; Larsen, R; Wilhelm, W; Wrobel, M | 1 |
| Connors, PM; Dershwitz, M; Dienstag, JL; Hoke, JF; Michałowski, P; Muir, KT; Rosow, CE | 1 |
| Dershwitz, M; Rosow, CE | 1 |
2 review(s) available for remifentanil and Liver Dysfunction
| Article | Year |
|---|---|
Topics: Adult; Aged; Analgesics, Opioid; Anesthetics, Inhalation; Animals; Antifungal Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Azoles; Candida albicans; Carbon Dioxide; Child; Chitosan; Chronic Periodontitis; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Environmental Monitoring; Female; Fluorides; Functional Residual Capacity; Gene Deletion; Genotype; Goats; Gold; Groundwater; Haplotypes; Humans; Infant; Insulin-Like Growth Factor II; Ketoconazole; Linkage Disequilibrium; Litter Size; Liver Diseases; Male; Metal Nanoparticles; Middle Aged; Nanocomposites; Pakistan; Peptides; Periodontal Attachment Loss; Periodontal Index; Plethysmography, Whole Body; Pneumoperitoneum, Artificial; Reference Standards; Remifentanil; Respiratory Function Tests; Respiratory Mechanics; Retrospective Studies; RNA-Binding Proteins; Sevoflurane; Sirolimus; Soot; Tidal Volume; Tumor Necrosis Factor Inhibitors; Water Pollutants, Chemical | 2021 |
[Remifentanil. An update].
Topics: Aging; Analgesics, Opioid; Anesthetics, Intravenous; Animals; Contraindications; Critical Care; Humans; Kidney Diseases; Liver Diseases; Pain, Postoperative; Piperidines; Remifentanil | 2003 |
2 trial(s) available for remifentanil and Liver Dysfunction
| Article | Year |
|---|---|
Topics: Adult; Aged; Analgesics, Opioid; Anesthetics, Inhalation; Animals; Antifungal Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Azoles; Candida albicans; Carbon Dioxide; Child; Chitosan; Chronic Periodontitis; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Environmental Monitoring; Female; Fluorides; Functional Residual Capacity; Gene Deletion; Genotype; Goats; Gold; Groundwater; Haplotypes; Humans; Infant; Insulin-Like Growth Factor II; Ketoconazole; Linkage Disequilibrium; Litter Size; Liver Diseases; Male; Metal Nanoparticles; Middle Aged; Nanocomposites; Pakistan; Peptides; Periodontal Attachment Loss; Periodontal Index; Plethysmography, Whole Body; Pneumoperitoneum, Artificial; Reference Standards; Remifentanil; Respiratory Function Tests; Respiratory Mechanics; Retrospective Studies; RNA-Binding Proteins; Sevoflurane; Sirolimus; Soot; Tidal Volume; Tumor Necrosis Factor Inhibitors; Water Pollutants, Chemical | 2021 |
Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease.
Topics: Adult; Analgesics, Opioid; Female; Humans; Liver Diseases; Male; Middle Aged; Piperidines; Remifentanil | 1996 |
6 other study(ies) available for remifentanil and Liver Dysfunction
| Article | Year |
|---|---|
The Requirement of Isoflurane and Remifentanil During Liver Transplantation Using Bispectral Index and Surgical Pleth Index: An Observational Study.
Topics: Anesthetics, Inhalation; End Stage Liver Disease; Humans; Isoflurane; Liver Diseases; Liver Transplantation; Remifentanil; Severity of Illness Index | 2022 |
Remifentanil upregulates hepatic IL-18 binding protein (IL-18BP) expression through transcriptional control.
Topics: Analgesics, Opioid; Animals; CCAAT-Enhancer-Binding Protein-beta; Cell Line; Hepatocytes; Humans; Intercellular Signaling Peptides and Proteins; Liver Diseases; Male; Mice; Rats, Sprague-Dawley; Remifentanil; Reperfusion Injury; STAT1 Transcription Factor; Up-Regulation | 2018 |
Remifentanil, fentanyl, or the combination in surgical procedures in the United States: predictors of use in patients with organ impairment or obesity.
Topics: Adult; Aged; Analgesics, Opioid; Anesthetics, Intravenous; Drug Therapy, Combination; Female; Fentanyl; Humans; Kidney Diseases; Liver Diseases; Male; Middle Aged; Obesity; Pain, Postoperative; Piperidines; Predictive Value of Tests; Remifentanil; Retrospective Studies; United States | 2015 |
Remifentanil preconditioning reduces hepatic ischemia-reperfusion injury in rats via inducible nitric oxide synthase expression.
Topics: Analgesics, Opioid; Animals; Arginine; Blotting, Western; Cell Survival; Cytokines; Disease Models, Animal; Ischemic Preconditioning; Lipid Peroxidation; Liver; Liver Diseases; Male; Naloxone; Narcotic Antagonists; Nitric Oxide Synthase; Piperidines; Rats; Rats, Sprague-Dawley; Remifentanil; Reperfusion Injury; Transaminases | 2011 |
The influence of the severity of chronic virus-related liver disease on propofol requirements during propofol-remifentanil anesthesia.
Topics: Adult; Anesthesia; Anesthetics, Intravenous; Chronic Disease; Electroencephalography; Hepatitis B, Chronic; Humans; Liver Diseases; Male; Middle Aged; Piperidines; Propofol; Remifentanil; Virus Diseases | 2013 |
The pharmacokinetics and pharmacodynamics of remifentanil in volunteers with severe hepatic or renal dysfunction.
Topics: Analgesics, Opioid; Case-Control Studies; Humans; Kidney Failure, Chronic; Liver Diseases; Piperidines; Remifentanil | 1996 |